Inflammatory Bowel Disease Drug Attacks Safe Haven for HIV (1 of 1) (video) American Association for the Advancement of Science Share Print E-Mail Loading video... Caption Saraubh Mehandru, senior author of the new study, discusses the findings and implications of the research. This material relates to a paper that appeared in the Oct. 3, 2018, issue of Science Translational Medicine, published by AAAS. The paper, by M. Uzzan at Icahn School of Medicine at Mount Sinai in New York, N.Y., and colleagues was titled, "Anti-a4ß7 therapy targets lymphoid aggregates in the gastrointestinal tract of HIV-1-infected individuals." Credit Mount Sinai Hospital Usage Restrictions Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact Science for permission. Share Print E-Mail Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.